Page 378 - Hall et al (2015) Principles of Critical Care-McGraw-Hill
P. 378

248     PART 3: Cardiovascular Disorders


                 dilution,  as described above. These two systems analyze the arterial   measures to define volume responsiveness. However, over the past 15
                       46
                 pulse differently. The PiCCO system uses a pulse contour analysis simi-  years numerous studies have validated the utility of positive-pressure
                 lar to that originally described by Hamilton and Remington in 1947,    ventilation-induced dynamic changes in either arterial pulse pressure
                                                                    43
                 and the LiDCO system uses a pulse power analysis. The LiDCOrapid™,   or stroke volume, referred to as pulse pressure variation (PPV) 10,11  and
                 Vigileo™ (Edwards Life Sciences), and MostCare™ (Vytech, Padova, Italy,   stroke volume variation (SVV), 53,54  respectively, to predict which criti-
                 using the Pressure Recording Analytical Method [PRAM]) systems are   cally ill patients will be volume responsive (see chap. 34).  A threshold
                                                                                                                 55
                 noncalibrated and estimate cardiac output from the arterial pressure   value of either PPV or SVV >10% to 15% defines volume responsive-
                 pulse using assumptions about arterial compliance using proprietary   ness when patients are passive while ventilated with a tidal volume of
                 algorithms.  The LiDCOrapid uses the pulse power approach of its pre-  8 mL/kg or more. These parameters are not accurate during arrhyth-
                         47
                 decessor LiDCOplus, whereas the Vigileo estimates arterial compliance   mias and spontaneous breathing because of varying R-R intervals and
                 from the wave form pressure distribution and the MostCare relies only   ventricular interdependence-induced changes in LV diastolic compli-
                 on the raw arterial pressure waveform. Recent head-to-head compari-  ance, respectively. In those cases, one can perform a passive leg raising
                 sons of most of the invasive and minimally invasive devices in critically   maneuver and note the transient increase in cardiac output. Postural
                 ill patients demonstrated significant intradevice variability,  suggesting   changes such as passive leg raising have been used for many years as
                                                            48
                 that if one were to use these devices, it is best to use one or two devices   a means to transiently increase venous return. The legs are raised to
                 only and become familiar with their strengths and limitations, rather   30° above the chest and held for 1 minute and the maximal increase in
                 than use several over time in the same patient. The level of accuracy and   cardiac output recorded. This maneuver approximates a 300-mL blood
                 precision of each device needs to be understood as the data cannot be   bolus in a 70-kg patient that persists for approximately 2 to 3 minutes. 56
                 superimposed from one system to another. The main advantage of these   The excitement about the arterial pulse contour analysis devices
                 arterial pressure–based cardiac output monitoring systems over PAC-  comes from their ability to rapidly measure PPV, SVV, and also the
                 derived measurements is their less invasive nature.   dynamic changes in cardiac output in response to PLR. These param-
                   Since all these devices presume a fixed relation between pressure   eters are profoundly robust across multiple clinical trials and allow the
                 propagation along the vascular tree and LV stroke volume, if vascular   bedside caregiver immediate insight into the volume responsiveness
                 elastance (reciprocal of compliance) changes, then these assumptions   of their patient. 51,57  Furthermore, when coupled with preoptimization
                 may become invalid. Thus, a major weakness of any pulse contour device   therapy  in  high-risk  surgical  patients  a  PPV  minimization  strategy
                 is the potential for artificial drift in reported values if major changes   markedly improved outcome.  Even when used as an adjuvant to
                                                                                              58
                 in arterial compliance occur. These points were illustrated well for the   document volume responsiveness using traditional fluid boluses, with
                 PiCCO device  in an animal model (Fig. 32-2) but probably apply to   the goal of achieving supranormal D O 2  levels, these monitoring devices
                            49
                 a greater or lesser extent to all devices. In an attempt to understand the   facilitate the easy implementation of treatment protocols that reduce
                 potential magnitude of this pathophysiologic effect, Hatib et al measured   acute postoperative complications 59-63  and improve long-term patient-
                 both aortic and radial arterial resistance, compliance and impedance in   centered outcomes.  And at the end of the day, is not that why we care
                                                                                     64
                 a pig model before and after the induction of hyperdynamic hypoten-  for our patients?
                 sive  endotoxic shock (Fig. 32-5).  Normally, the arterial pulse pressure
                                         50
                 increases as blood flow moved peripherally owing to the normal elastic   Acknowledgment:  This  study  was  supported  in  part  by  NIH  grants
                 properties of the arterial tree. However, in the hyperdynamic hypotensive   HL067181, and HL073198.
                 state of fully developed sepsis the pressure trend is reversed with higher   Conflicts of interest: The author is a paid consultant to Edwards
                 central than peripheral pulse pressures owing to a marked increase in   LifeScience and LiDCO Ltd and has stock options with LiDCO Ltd. The
                 peripheral  vascular  compliance  presumably  due  to  endotoxic  vasople-  author is the inventor of a University of Pittsburgh-owned US patent on
                 gia, whereas aortic compliance is increased, presumably due to intimal   using pulse pressure and stroke volume variation to diagnose and treat
                 edema. Clearly, algorithms that were developed assuming one specific   hemodynamic insufficiency.
                 physiological state will degrade in the other.

                 FUNCTIONAL HEMODYNAMIC MONITORING                       KEY REFERENCES

                 A primary question asked of all hemodynamically unstable patients is     • Cannesson M, Besnard C, Durand PG, Bohe J, Jacques D. Relation
                 their response to volume resuscitation (ie, will they increase their car-  between respiratory variations in pulse oximetry plethysmo-
                 diac output in response to fluid loading?).  Knowing fluid responsive-  graphic waveform amplitude and arterial pulse pressure in ven-
                                                51
                 ness would be a very valuable piece of information in planning acute   tilated patients. Crit Care. 2005;9:R562-R568. [first clinical study
                 resuscitation strategies. Since efforts to rapidly increase blood flow are   showing that the pulse oximeter plethysmographic density profiles
                 important to minimize tissue ischemia and organ dysfunction, defining   could be used as a surrogate for arterial pulse pressure to assess
                 those treatments that will quickly increase cardiac output are essential.   volume responsiveness]
                 Traditionally,  bedside  caregivers  gave  all  hemodynamically  unstable
                 and/or hypotensive patients a rapid fluid bolus to assess their volume     • Gomez H, Torres A, Polanco P, et al. Use of non-invasive NIRS
                 responsiveness. If heart rate decreased, blood pressure increased, or   during a vascular occlusion test to assess dynamic tissue O
                                                                                                                         2
                 other measure of tissue perfusion suggested improvement (eg, increased   saturation response. Intensive Care Med. 2008;34:1600-1607. [first
                 urine output, increase sensorium, decreased serum lactate), the patients   clinical study to examine the determinants of St O 2  change during the
                 were deemed volume responsive and given massive fluid resuscitation   vascular occlusion test]
                 until  no  longer  responsive.  Hemodynamic  monitoring  serves  to  help     • Hadian M, Kim H, Severyn DA, Pinsky MR. Cross-comparison
                 define those patients likely to be volume responsive and to monitor their   of cardiac output trending accuracy of LiDCO, PiCCO, FloTrac
                 course during fluid resuscitation because volume overload itself is also   and pulmonary artery catheters. Crit Care. 2010;14:R212. [clini-
                 dangerous. Static measures of cardiac filling pressure or even volumes   cal study comparing most commercially available cardiac output
                 do not predict who is going to be volume responsive and who will not.   monitoring devices to each other]
                 Using the traditional threshold of at least a 15% increase in cardiac out-    • Hamilton WF, Remington JW. The measurement of stroke volume
                 put in response to a 300-mL colloid bolus to define volume responsive-  from the pulse pressure. Am J Physiol. 1947;148:14-24. [the original
                 ness, Michard and Teboul  in their systematic review were unable to   study on use of pressure pulse to assess flow in a canine model]
                                     52
                 identify any consistent clinical data to support the use of these  traditional







            section03.indd   248                                                                                       1/23/2015   2:06:52 PM
   373   374   375   376   377   378   379   380   381   382   383